Perilipin-5 as a potential new biomarker in patients with liver disease and impaired De Ritis ratio

Year 2021, Volume: 46 Issue: 4, 1321 - 1326, 30.12.2021

İbrahim Ethem Şahin , Ceyhan Hacıoğlu , Fatih Davran , Merve Alpay

https://doi.org/10.17826/cumj.975899

Abstract

Purpose: Liver dysfunctions are one of the most prevalent and deadly diseases worldwide. The De Ritis ratio, which is obtained by proportioning serum aspartate aminotransferase (AST) and serum alanine aminotransferase (ALT), has been suggested to be a precious marker to assess the prognosis of liver diseases. This study was to investigate the relationship between perilipin 5 (PLIN5) levels and De Ritis ratio in patients with liver disease.
Materials and Methods: There were 3 groups: control (Group1; n=20), hepatic patients with normal De Ritis ratio (Group2; n=35) and hepatic patients with impaired De Ritis ratio (Group3; n=35). De Ritis rates of all patients were determined according to the serum aspartate aminotransferase (AST)/serum alanine aminotransferase (ALT) results. Additionally, PLIN5 was spectrophotometrically analyzed from serum samples.
Results: There is no significant difference between the groups in terms of age and gender. PLIN5 levels increased by 2.6 and 3.8 times in Group2 and Group3, respectively. De Ritis ratio was significantly increased in the Group3 compared the control, and enhanced PLIN5 levels was correlated with De Ritis ratio in the Group3. There was a significant positive correlation between De Ritis ratio and PLIN5 levels.
Conclusion: PLIN5 levels together with De Ritis rate in liver patients may be used as a prognostic marker. Furthermore, this relationship could be a useful method in the follow-up of liver diseases.

Keywords

De Ritis ratio, Perilipin5, Liver damage, AST, ALT

Karaciğer hastalığı ve bozulmuş De Ritis oranı olan hastalarda potansiyel yeni bir biyobelirteç olarak perilipin-5

Abstract

Amaç: Karaciğer fonksiyon bozuklukları dünya çapında en yaygın ve ölümcül hastalıklardan biridir. Serum aspartat aminotransferaz (AST) ve serum alanin aminotransferazın (ALT) oranlanmasıyla elde edilen De Ritis oranının, karaciğer hastalıklarının prognozunu değerlendirmek için değerli bir belirteç olduğu öne sürülmüştür. Bu çalışma, karaciğer hastalığı olan hastalarda perilipin 5 (PLIN5) düzeyleri ile De Ritis oranı arasındaki ilişkiyi araştırmak amacıyla yapılmıştır.
Gereç ve Yöntem: Kontrol (Grup1; n=20), normal De Ritis oranı olan karaciğer hastaları (Grup2; n=35) ve De Ritis oranı bozulmuş karaciğer hastaları (Grup3; n=35) olmak üzere 3 grup vardı. Tüm hastaların De Ritis oranları serum aspartat aminotransferaz (AST) / serum alanin aminotransferaz (ALT) sonuçlarına göre belirlendi. Ek olarak, PLIN5, serum örneklerinden spektrofotometrik olarak analiz edildi.
Bulgular: Gruplar arasında yaş ve cinsiyet açısından anlamlı fark yoktu. PLIN5 seviyeleri Grup2 ve Grup3'te sırasıyla 2,6 ve 3,8 kat arttı. De Ritis oranı, kontrole kıyasla Grup3'te önemli ölçüde arttı ve artan PLIN5 seviyeleri, Grup3'teki De Ritis oranı ile korele idi. De Ritis oranı ile PLIN5 seviyeleri arasında anlamlı pozitif korelasyon vardı.
Sonuç: Karaciğer hastalarında De Ritis oranı ile birlikte PLIN5 düzeyleri, prognostik bir belirteç olarak kullanılabilir. Ayrıca bu ilişki karaciğer hastalıklarının takibinde faydalı bir yöntem olabilir.

Keywords

De Ritis oranı, Perilipin5, Karaciğer hasarı, AST, ALT

References

• DE RITIS F, COLTORTI M, GIUSTI G. An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. Clin Chim Acta 1957;2(1):70-4.
• Tao Y, Wang M, Chen E, Tang H. Liver Regeneration: Analysis of the Main Relevant Signaling Molecules. Mediators Inflamm 2017;2017:4256352.
• Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 2008;59(1):107-17.
• Vagvala SH, O'Connor SD. Imaging of abnormal liver function tests. Clin Liver Dis (Hoboken) 2018;11(5):128-34.
• Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 2017;112(1):18-35.
• Tygstrup N. Assessment of liver function: principles and practice. J Gastroenterol Hepatol 1990;5(4):468-82.
• Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172(3):367-79.
• Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med 2002;40(7):718-24.
• Rekha M, Jayaprakash Murthy DS, Purnima RT, Dattatreya K. Evaluation of De Ritis ratio, alkaline phosphatase and bilirubin in liver diseases. J Pharm Sci Res, 2011;3:1096-102.
• Bickel PE, Tansey JT, Welte MA. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta 2009;1791(6):419-40.
• Dalen KT, Dahl T, Holter E, et al. LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues. Biochim Biophys Acta 2007;1771(2):210-27.
• Trevino MB, Mazur-Hart D, Machida Y, et al. Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice. Mol Endocrinol 2015;29(10):1414-25.
• Wang C, Zhao Y, Gao X, et al. Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology 2015;61(3):870-82.
• Kuramoto K, Okamura T, Yamaguchi T, et al. Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation. J Biol Chem 2012;287(28):23852-63.
• Gemmink A, Bosma M, Kuijpers HJ, et al. Decoration of intramyocellular lipid droplets with PLIN5 modulates fasting-induced insulin resistance and lipotoxicity in humans. Diabetologia 2016;59(5):1040-8.
• Majhi S, Baral N, Lamsal M, Mehta KD. De Ritis ratio as diagnostic marker of alcoholic liver disease. Nepal Med Coll J 2006;8(1):40-2.
• Botros M, Sikaris KA, Lu ZX, McNeil A. The short term prognostic usefulness of the De Ritis ratio. Clin Biochem Rev 2013;34:1-18.
• Hietala J, Puukka K, Koivisto H, Anttila P, Niemela O. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. Alcohol Alcohol 2005;40(6):511-14.
• Hann HW, Wan S, Myers RE, et al. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One 2012;7(10):e47687.
• Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 2004;39(4):336-9.
• Zamin JI, de Mattos AA, Perin C, Ramos GZ. A importância do índice AST/ALT no diagnóstico da esteatohepatite não-alcoólica [The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis]. Arq Gastroenterol 2002;39(1):22-6.
• Spreafico F, Sales RC, Gil-Zamorano J, et al. Dietary supplementation with hybrid palm oil alters liver function in the common Marmoset. Sci Rep 2018;8(1):2765.
• Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C, Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res 2010;51(3):468-71.
• Keenan SN, Meex RC, Lo JCY, et al. Perilipin 5 Deletion in Hepatocytes Remodels Lipid Metabolism and Causes Hepatic Insulin Resistance in Mice. Diabetes 2019;68(3):543-55.
• Asimakopoulou A, Vucur M, Luedde T, et al. Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma. Cancers (Basel) 2019;11(3):385.